The 2o to 25 nm particles of hepatitis B surface antigen were purified from the serum of a carrier chimpanzee. Five major polypeptide species were revealed by sodium dodecyl sulphate-polyacrylamide gel electrophoresis. Treatment of the particles with neuraminidase (EC 3.2. I. 18) and galactose oxidase (EC I. I. 3.9) followed by reduction with tritiated sodium borohydride labelled galactose residues in a single glycoprotein with an apparent mol. wt. of 28 ooo. The glycoprotein was not labelled when neuraminidase treatment was omitted, indicating that the galactose residues are in subterminal positions in the oligosaccharide chains. There was no significant incorporation of radiolabel into lipid. The serological activity of the antigen, as measured by a competitive double-antibody radioimmunoprecipitation assay, was not altered by the labelling procedure nor by exposure to neuraminidase alone.
INTRODUCTION
Hepatitis B surface antigen (HBsAg) is found in the serum of persons infected with hepatitis B virus (HBV). Electron microscopy has shown clearly the close association of HBsAg with a number of distinct morphological forms, the predominant particle being a pleomorphic 20 to 25 nm sphere with little or no discernible surface structure (Howard & Burrell, I976) . Filamentous forms of similar diameter but varying in length are also frequently seen together with a larger double-shelled 42 nm particle, both of which react with antiserum to HBsAg (anti-HBs). The latter particle is currently thought to represent the virus of hepatitis type B (W.H.O., I976), consisting of an outer lipoprotein coat which surrounds an inner core component with unique serological reactivity (HBcAg: Almeida et al. 197 0. At least a proportion of these complex particles contains circular DNA of mol. wt. 1.6 to 2.0 x lO s which is thought to represent the whole or part of the virus genome (Robinson, ~974; Gerin et al. I975) . Early studies showed that the administration of immunoglobulin containing a high titre of anti-HBs may protect from HBV infection (Prince et al. 1970 . Furthermore, it was found that serum containing the virus may be used effectively for prophylaxis following heat inactivation (Krugman et al. 197 0-These findings have collectively prompted extensive studies as to the potential use of purified HBsAg particles or subunits for the immunization against HBV.
Previous studies have indicated the importance of HBsAg carbohydrate both in its reaction with antibody and in stimulating an immunological response (Burrell et al. I973; Neurath et al. I975) . Recently the radiolabelling of oligosaccharides present on the surface of both cells and viruses has been achieved (Gahmberg, I976; McLellan & August, I976; Luukkonen et al, 1977) . The specific oxidation of galactose and galactosamine residues was accomplished by the use of the enzyme galactose oxidase and the resulting C-6 aldehydes were reduced with tritiated sodium borohydride. This approach unambiguously identifies glycoproteins and provides information as to their positions on the surface of the structure being examined. In addition, the introduction of radiolabel into the oligosaccharide moieties of glycoproteins facilitates their isolation for further biochemical and antigenic analysis. This procedure was therefore used for the study of HBsAg oligosaccharide moieties present on purified 2o to 25 nm particles.
METHODS
Hepatitis B surface antigen. An t I-year-old female chimpanzee persistently infected with HBV was used as a source of HBsAg. Large volumes of antigen-containing plasma were regularly obtained by plasmapheresis at monthly intervals. The titre of HBsAg present was assayed by a reverse passive haemagglutination (RPHA) method (Hepatest, Wellcome Reagents Ltd., Dartford, U.K.). The antigen subdeterminants were characterized as adw by Dr J. P. Soulier, National Blood Transfusion Service, Paris.
Purification of HBsAg. Plasma containing H BsAg was initially centrifuged at 20 ooo rev/min (5zooog) for 4 h at 4 °C in a Beckman SW27 rotor in order to remove HBV particles. The remainder of the hepatitis B antigens were then pelleted from the supernatant by centrifugation at 25ooo rev/min (83 ooo g) for 18 h at 4 °C in the SW27 rotor. Two pellets were resuspended in Io ml of phosphate-buffered saline (PBS), and layered on top of 3"5 ml of 5o % (w/v) CsC1. After centrifugation at 35o00 rev/min (229000 g') at 4 °C for I8 h in a Beckman SW4o rotor, fractions (0"5 ml) were collected from the top of the tube and assayed for the presence of antigen by reverse passive haemagglutination. Peak fractions were pooled and the density was adjusted to 1.3o g/ml by the addition of solid CsC1. This material was then incorporated into discontinuous CsCl gradients consisting of four layers of densities I.io, 1.2o, 1.3 o and 1.4o g/ml buffered with o.oi M-tris-HCl, pH 7"3, and centrifuged at 35000 rev/min (229ooog) at 4 °C for I8 h in an SW4o rotor. Fractions containing the antigen were pooled, dialysed against PBS for 18 h at 4 °C, and 2 ml volumes were layered on to 15 ml discontinuous IO to 25% gradients of Urografin (Schering Chemicals Ltd., Burgess Hill, Sussex, U.K.) buffered with o.ot M-tris-HC1, pH 7"3. After centrifugation at 2oooo rev/min (5zooog) at 4 °C for 28 h, the fractions containing antigen were pooled and Urografin was removed by passing 5 ml portions through a 27 × I-5 cm column of Sephadex G-75 equilibrated with o.oi M-tris-HC1, pH 7"3-Electron microscopy. Samples of purified antigen were stained with 2 % phosphotungstic acid in distilled water and the stained suspensions applied to carbon.formvar-coated Smithhurst no. 4oo copper grids. Excess fluid was removed and the grids were immediately examined in an AEI 8oi electron microscope operated at 8o kV.
Labelling ofgalactose residues. The method of Luukkonen et al. (I977) was followed. Neuraminidase from Vibrio eholerae (Calbiochem, U.S.A.) and galactose oxidase (Kabi AB, Stockholm, Sweden) were deemed to be free of any proteolytic effect on the antigen polypeptides as determined by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE). Tritiated sodium borohydride (NaWH~; 870 mCi/mmol) was obtained from the Radiochemical Centre, Amersham, and diluted with o.oi M-NaOH prior to storage at -7 o °C (Gahmberg, 1976 ) . The complete reaction mixture contained I2o#g of purified HBsAg, i2. 5 units of neuraminidase, and 25 units of galactose oxidase in 200 #1 of o'oi5 Mtris-HC1, pH 7"3. In control samples, neuraminidase or both enzymes were omitted. After incubation at 37 °C for I h, 2oo #Ci of NaBZH4 in 3o #1 of O.Ol M-NaOH was added to each sample and the reaction was allowed to proceed at room temperature for 3o min. Excess NaBZH~, and the enzymes, were separated from the antigen on a I × Io cm column of Sephadex G-75 equilibrated with o.oI M-tris-HC1, pH 7"3.
Sucrose gradient analysis of labelled antigen. Samples of labelled antigen were centrifuged through ][2. 5 mI linear to to o/ 3o/o sucrose gradients buffered with o.oi M-tris-HC1, pH 7"4, 0"5 M-NaC1, ][ mM-EDTA, at 35000 rev/min (229000 g) for 6 h at 4 °C in a Beckman SW4o rotor. Fractions (o'5 ml) were collected from the top of the tube, and assayed for radioactivity. Samples of each fraction were dried on glass-fibre filters (Grade GF/B Whatman) and precipitated with lOO ml of 5% trichloroacetic acid (TCA) for 18 h. The discs were then washed with two ][ oo ml volumes of TCA, followed by two lOO ml volumes of ethanol, dried and immersed in scintillation fluid for counting.
Identification of the labelled sugar. A portion of HBsAg labelled as described above was diluted to 5 ml with O.Ol M-tris-HC1 buffer and pelleted at 59000 rev/min (25oooog) for I8 h at 4 °C in a Beckman SW65 rotor. The pellet was resuspended in 0"5 ml of water, and samples containing IOOOOO ct/min were taken for acid hydrolysis. One sample was hydrolysed with 2 M-HCI at ioo °C for 4 h, and a second sample was hydrolysed with 4 M-HC1 at lOO °C for 6 h in order to release neutral sugars and amino sugars respectively (Spiro, ] [966). The acid was then removed by drying the samples and the hydrolysates were redissolved in o.2 ml of water and applied to small o'25 × 4 cm columns of Dowex 5o-H +. The columns were eluted with six 2 ml vol. of water to remove neutral sugars, followed by six 2 ml vol. of 0.2 M-HC1 to remove amino sugars. Samples of each fraction were dried on glass-fibre discs and counted. All radioactivity applied was recovered in the neutral sugar fraction regardless of the hydrolysis conditions used. This fraction was lyophilized, and su~ected to descending chromatography on Whatman No. ][ paper in n-butanol-ethanolwater 0o: 1:2 by vol.) for 96 h, together with galactose, glucose, galactosamine, glucosamine and mannose standards. The standard sugars were detected by the silver nitrate-sodium hydroxide method of Trevelyan et al. (][950) . Radioactive areas were located by slicing the sample lanes into I cm strips. Each strip was immersed in I ml of water in scintillation vials and 24h later Io ml of toluene-Triton X-][oo (3:][ by vol., containing 4 g/1 PPO and o'I g/1 dimethyl-POPOP) was added prior to counting.
Extraction of lipids from labelled antigen.
Labelled antigen was obtained from a sucrose gradient centrifugation as described above. Sucrose was removed from the antigencontaining fractions using a small pre-packed column of Sephadex G-25 and I mg of unlabelled antigen was added as a carrier. Twenty volumes of chloroform-methanol (2: I by vol.) were added, and the mixture heated at 40 °C for ][ 5 min. The precipitated protein was recovered by centrifugation at 2ooo rev/min for Io min. The precipitate was extracted once more with chloroform-methanol (2: I by vol.)and then once with chloroform-methanol (I : 2 by vol.). The extracts were combined, dried and redissolved in chloroform-methanolwater (4o:56:14 by vol.) for counting.
Polyacrylamide gel electrophoresis. Samples for electrophoretic analysis were disrupted for 2min at Ioo °C in o'][ M-tris-phosphate, pH6.7, buffer containing 20/o SDS, 50/0 2-mercaptoethanol, ~o ~o glycerol. Bromophenol blue was added as a tracking dye. Ten per cent acrylamide cylindrical resolving gels were prepared from a 28.6 %, w/v, stock solution containing ~'4%, w/v, methylene bis-acrylamide and buffered with 0.375 M-tris-HC1, pH 8"9. A stacking gel consisting of 3 ~o acrylamide buffered with 0.08 M-tris-phosphate, pH 6"7, was overlaid and samples electrophoresed for 1.5 to 2.0 h at 2"5 mA/gel. Separated components were visualized by staining with Coomassie brilliant blue (Weber & Osborn, 969) . Radioactivity was detected by the immersion of I mm slices in I ml Nuclear Chicago Solubilizer (Amersham-Searle) containing ~o % water. Ten ml of a toluene-based scintillation fluid was added after incubation for 2 h at 6o °C.
Radioimmunoprecipitation assay. The serological activity of antigen subjected to various enzyme treatments was examined by comparing the slopes of antigen dilution curves in a double-antibody radioimmunoprecipitation (RIP) assay (Burrell et al. 1973 (Burrell et al. , 1976 . Samples in I oo #1 aliquots were mixed with I oo/zl of a I/27oo dilution of rabbit anti-HBsAg (Hoechst Pharmaceuticals, Hounslow, Middlesex) and incubated at 37 °C for 3 h. HBsAg from the same source and purified as outlined above was radiolabelled with N-succinimidyl 3-(4-hydroxy, 5-1~sI-iodophenyl) propionate (BoRon & Hunter, I973) to a specific activity of about 5 #Ci/#g and used as the radioligand. Twenty/~1 (I I ooo ct/min) was added to each sample and incubation was continued for I8 h at 4 °C. Goat anti-rabbit IgG (Hoechst Pharmaceuticals: 2/Zl) was added, and after a further incubation for I8 h at 4 °C, the tubes were centrifuged at zooo rev/min for Io min. The supernatants and pellets were separated and counted, and the percentage of 125I-HBsAg precipitated was determined. The buffer used throughout was o'o5 M-tris-HC1, pH 7"4, containing 1% non-immune rabbit serum. 
RESULTS

Purification of HBsAg from chimpanzee serum
The purification procedure followed involved a concentration of the antigen by pelleting, a further separation from serum proteins by centrifugation on to a CsCI cushion, isopycnic banding in a CsCI gradient, and finally rate-zonal centrifugation in a gradient of Urografin. The specific activity and the recovery of antigen at each stage of the purification is shown in Table T . There was almost complete recovery of serological activity from each of the first three steps. Although only 28 % of serological activity was recovered after rate-zonal centrifugation in Urografin gradients, this compared favourably with a recovery of I 1% obtained using sucrose gradients. The final preparation was purified 463-fold, and electron microscopy showed that it consisted almost entirely of small, spherical 2o to 25 nm particles, together with a few short filaments (Fig. I) . The very high levels of antigen present in chimpanzee serum gave rise to yields of purified antigen (I 5 to 2o mg of protein from 45 °ml of serum) and were about Io-fold greater than those obtainable from human serum following the same procedure.
Estimation of total neutral hexose and sialie acid
Purified HBsAg contained 23'5 #g/mg protein of neutral hexose, as determined by the phenol-sulphuric acid assay and 16. 4 #g/rag protein of sialic acid by the resorcinol assay.
Labelling of HBsAg using galactose oxidase and NaB3H4
The conditions necessary for labelling HBsAg carbohydrates were investigated by comparing the incorporation of tritium from NaBaH4 after galactose oxidase and neuraminidase treatment, after galactose oxidase treatment only and after no enzyme treatment. Sucrose gradient analysis of the products of each reaction (Fig. 2) showed that labelling was most efficient when the antigen had been pre-treated with both neuraminidase and galactose oxidase, suggesting that removal of sialic acid residues made additional residues accessible to the latter enzyme. The specific activity attainable in these optimal conditions was, on average, 2. 5 × io 6 ct/min/mg protein. Since it was of interest to determine the distribution of label between glycolipid and glycoprotein the percentage of radioactivity extractable by chloroform-methanol mixtures was also measured. Only a small proportion (~'5 %) of the radioactivity was recovered in the lipid fraction. Furthermore, 82 ~o of the label was precipitated by TCA. The fact that this figure is not greater in view of the very small amount (3--(3) . Equal amounts of HBsAg protein were fractionated on Jo to 3o ~ linear sucrose gradients, and 5o/~1 samples of each fraction were TCA-precipitated and counted as described in Methods.
of label in the lipid fraction may be due to an increased loss of tritium as a result of exchange in acid solutions. This loss was also seen following acid hydrolysis for the identification of labelled sugars. It seemed clear, however, that the majority of the label was incorporated into glycoprotein.
Polyaerylamide gel electrophoresis of labelled glycoproteins
Examination of the polypeptide profiles of unlabelled HBsAg by SDS-PAGE revealed five major species with apparent tool. wt. of 64ooo, 32ooo, 3oooo, 28ooo and 23ooo (Fig. 3 ). An examination of labelled antigen revealed that radioactivity was present in a single species with an apparent tool. wt. of 28ooo (Fig. 4a) . This species probably corresponds to the 28 ooo tool. vvt. polypeptide detected in unlabelled antigen. No significant labelling of this glycoprotein occurred in the absence of pre-treatment with neuraminidase ( Fig. 4b) , nor was there any non-specific labelling of polypeptides in a control antigen preparation which was not pre-treated with either enzyme (data not shown). These findings suggest that the 28ooo tool. wt. glycoprotein possesses terminal sialic acid residues, with galactose or galatosamine residues present in subterminal positions.
Identification of the labelled sugars
As the enzyme galactose oxidase will oxidize both galactose and galactosamine residues, an identification of the labelled sugars was undertaken. HBsAg labelled with tritium was hydrolysed with z M-or 4 M-HCI to release neutral hexoses or amino sugar respectively, as described in Methods. In both cases, all the radioactivity in the hydrolysates could be eluted with water from cation exchange columns, indicating that no labelled amino sugars were present. Paper chromatography of the neutral sugar fraction identified galactose as the only labelled sugar present (Fig. 5) . Equal amounts of protein were disrupted and electrophoresed in IO ~ gels at a constant current of 2"5 mA/gel. The gels were fixed and sliced, and the slices were counted as described in Methods. The tool. wt. of the labelled material was derived by comparison with a parallel gel containing reference proteins of known tool. wt.
Serological analysis
In view of the suggested importance of carbohydrate in the antigenic reactivity of HBsAg it might be expected that any modification of the oligosaccharide portion of HBsAg glycoprotein during the labelling reaction would alter the affinity of HBsAg for its antibody. Accordingly, serial dilutions of HBsAg subjected to neuraminidase treatment alone, or to neuraminidase, galactose oxidase and tritiated NaBaH4, were compared with control antigen in a competitive double-antibody RIP assay. It was apparent that neither treatment altered the slopes of the dilution curves from those of the control samples (Fig. 6a, b) , indicating that there was no effect on the affinity of HBsAg for its antibody as a result of exposure to the reagents used during the labelling procedure.
DISCUSSION
The repeated failure of attempts to cultivate HBV using standard virological procedures has led to the extensive use of sera from persistently infected carriers as a source of HBV and its antigens. Although the HBsAg 20 to 25 nm particles are readily separated from unwanted serum proteins, the exact biochemical nature of HBsAg remains to be firmly HBsAg. Antigen (0.68 mg protein/ml) in 2oobd of o.oI M-tris-HCl, pH 7"3, was incubated at 37 °C for ] h with 12"5 units of neuraminidase. The control sample contained no enzyme. Each sample was diluted 2 : 50 with 0"05 M-tris-HC1, pH 7"4, containing 2 ~ normal rabbit serum. Serial fourfold dilutions in this buffer were then assayed as described in Methods. (b) Radioimmunoprecipitation assay of control (@--@) and tritium labelled (O--Q) HBsAg. Antigen (0"68 mg protein/ml) in 2oo#1 of 0'02 M-tris-HCl, pH 7"3, was incubated for 2 h at 37 °C with I2'5 units of neuraminidase and 25 units of galactose oxidase. After reduction with NaB3H4 (3oo#Ci) for 30 rain at room temperature excess NaB3H4 was removed on a column of Sephadex G-75. The control sample was untreated. Serial fourfold dilutions were assayed as described in Methods.
established. Reported estimates as to the percentage weight of protein in these lipoproteins vary widely from 4o to 7o % (for a review see Howard & Burrell, 1976) . Since the initial findings of Cawley (1972) and Burrell et al. (1973) (1973) estimated the carbohydrate content of HBsAg at 3"6 to 6"5 % using the phenolsulphuric acid method. Recently a more detailed gas chromatographic analysis has indicated a total carbohydrate content of 7"6% (Shiraishi et aL t977). These workers also demonstrated the presence of galactose, mannose, fucose, glucosamine and sialic acid. In addition, the carbohydrate was entirely in the form of glycoprotein. This contrasts with the report of Steiner et al. 0974) who found the presence of glycosphingolipid. In the present study, HBsAg particles purified free from serum proteins by isopycnic centrifugation followed by sedimentation in gradients of Urografin were found to possess a neutral sugar content approaching 2-4%, a value similar to that of 2"I5~o reported by Shiraishi et al. U977)-However, the sialic acid content in this study was found to be considerably higher at 1.64 ~o as compared to their figure of o'87 %. This discrepancy may arise from the different sources and antigenic subtypes of the HBsAg studied, since the sialic acid content of viruses is subject to a variation dependent upon the host cell (Etchison & Holland, I974; Keegstra et al. I975) .
The identification of HBsAg glycoproteins has largely relied upon their initial separation by SDS-acrylamide gel electrophoresis followed by staining with periodate-Schiff (PAS) stain. 0975) showed that the addition of 14C-siatic acid on to desialyated HBsAg in the presence of sialyl transferase resulted also in the identification of a 26o0o mol. wt. glycoprotein component. Except for the common finding of a structure in the 26oo0 to 28ooo mol. wt. range by several workers, there are discrepancies as to the number and size of HBsAg glycoproteins detected by selective staining of SDS gels. This may be a reflection of the uncertainties of the PAS staining method (Glossman & Neville, I97I) .
Using the enzyme galactose oxidase for the oxidation of carbohydrate residues, a single glycoprotein with an apparent mol. wt. of 28 ooo was identified in desialyated HBsAg as a result of the uptake of tritium label after reduction by NaB3H4 (Fig. 4a) . This species probably corresponds to the glycoprotein of similar size reported by other laboratories.
All the radioactive label was found to be incorporated into the galactose residues of glycoprotein, in agreement with the data of Shiraishi et al. (I977) who did not detect any galactosamine in HBsAg. The absence of label in glycolipid also supports their observation that there was no detectable sugar in the lipid fraction. Nevertheless, the presence of glycolipid as reported by Steiner et al. (t974) , cannot be entirely excluded by our results since such a component either might not contain terminal galactose or galactosamine residues, or might be inaccessible to the enzyme due to its position in the particle.
The observation that labelling was more efficient after neuraminidase treatment suggests that the glycoprotein has terminal sialic acid in some of its oligosaccharide moieties, and that this is linked to sub-terminal galactose residues. The oligosaccharides are therefore of the A-type (Johnson & Clamp, I970 , which are complex branched structures containing sialic acid, fucose, glucosamine, galactose and mannose. This type of structure has been found in glycoproteins of Semliki Forest virus (Mattila et al. 1976) , Sindbis virus (Sefton & Keegstra, 1974) , vesicular stomatitis virus (Etchison et al. I977) and avian tumour viruses (Sefton, I976) . A second simpler oligosaccharide structure (B type) containing only mannose and glucosamine, is also likely to be present in HBsAg glycoproteins in view of the high content of these two sugars found by Shiraishi et al. (I977) . A glycoprotein containing only B-type structures would not be labelled by the galactose oxidase/NaBSH4 procedure; hence it is not certain that all HBsAg glycoproteins are identified by this procedure.
It was important to confirm that the conditions required for radiolabelling of the carbohydrate did not affect the serological activity of HBsAg. Immunoprecipitation studies showed that the affinity of HBsAg for its antibody was not altered either by neuraminidase alone, or by the combined action of neuraminidase, galactose oxidase, and tritiated sodium borohydride.
The 
